Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis|
|Citation:||Biochemical Society Transactions, 2012; 40(1):168-172|
|Valentina Iadevaia, Yilin Huo, Ze Zhang, Leonard J. Foster and Christopher G. Proud|
|Abstract:||mTORC1 (mammalian target of rapamycin complex 1) is controlled by diverse signals (e.g. hormones, growth factors, nutrients and cellular energy status) and regulates a range of processes including anabolic metabolism, cell growth and cell division. We have studied the impact of inhibiting mTOR on protein synthesis in human cells. Partial inhibition of mTORC1 by rapamycin has only a limited impact on protein synthesis, but inhibiting mTOR kinase activity causes much greater inhibition of protein synthesis. Using a pulsed stable-isotope-labelling technique, we show that the rapamycin and mTOR (mammalian target of rapamycin) kinase inhibitors have differential effects on the synthesis of specific proteins. In particular, the synthesis of proteins encoded by mRNAs that have a 5′-terminal pyrimidine tract is strongly inhibited by mTOR kinase inhibitors. Many of these mRNAs encode ribosomal proteins. mTORC1 also promotes the synthesis of rRNA, although the mechanisms involved remain to be clarified. We found that mTORC1 also regulates the processing of the precursors of rRNA. mTORC1 thus co-ordinates several steps in ribosome biogenesis.|
|Keywords:||mammalian target of rapamycin (mTOR); mRNA; protein synthesis; rapamycin; ribosome biogenesis; translation factor|
|Rights:||© The Authors|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.